KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $147.5 million.

  • Resmed's Gains from Investment Securities rose 2435.71% to $147.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $199.1 million, marking a year-over-year decrease of 3954.68%. This contributed to the annual value of $214.0 million for FY2025, which is 2312.75% down from last year.
  • Latest data reveals that Resmed reported Gains from Investment Securities of $147.5 million as of Q4 2025, which was up 2435.71% from $61.9 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Gains from Investment Securities peaked at $345.9 million during Q3 2021, and registered a low of -$26.5 million during Q1 2025.
  • Moreover, its 5-year median value for Gains from Investment Securities was $54.0 million (2022), whereas its average is $74.0 million.
  • As far as peak fluctuations go, Resmed's Gains from Investment Securities skyrocketed by 353436.52% in 2021, and later crashed by 14290.06% in 2025.
  • Resmed's Gains from Investment Securities (Quarter) stood at $37.0 million in 2021, then skyrocketed by 47.45% to $54.5 million in 2022, then soared by 77.25% to $96.7 million in 2023, then rose by 22.71% to $118.6 million in 2024, then increased by 24.36% to $147.5 million in 2025.
  • Its Gains from Investment Securities stands at $147.5 million for Q4 2025, versus $61.9 million for Q3 2025 and $16.2 million for Q2 2025.